An interventional study of Technology-based Intervention in Housing Problems, Household Substance Abuse and Substance Use Disorders, sponsored by Oregon Research Behavioral Intervention Strategies, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-13.
Sponsored by Oregon Research Behavioral Intervention Strategies, Inc. (part of Influents Innovations) · Not applicable, Interventional, and Supportive care
The goal of this clinical trial is to understand whether a technology-based solution, provided to residents in permanent supportive housing, is acceptable, feasible to implement, and has promise for improving resident stability. The main questions it aims to answer are:
There is no comparison group, all participants will receive the technology-based intervention. Researchers expect the intervention will include 2 weeks of intervention content that includes videos and incentives for completing content though the solution tested will ultimately be co-defined by our community board.
Our clinical trial is a pre-post assessment of resident knowledge.
2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.
This study's enrollment of 15 is below the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →Oregon Research Behavioral Intervention Strategies, Inc. is the lead sponsor of 24 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Residents:
Staff:
All participants will be assigned to the intervention, which includes exposure to the technology-based solution while participants are housed within permanent supportive housing. It is anticipated that the intervention will deliver a total of 10 sessions of harm reduction focused cognitive behavioral skills and skills applications. A total of 20 skills practice sessions are also included. Financial incentives are provided up to $50 for completion of sessions and skills practice.
Behavioral: Technology-based Intervention
Technology-based intervention co-developed by a community board.
Knowledge
Knowledge is gain in knowledge related to Cognitive Behavioral Therapy (CBT) skills and life skills taught by the intervention as the number of items answered correctly.
Time frame: baseline; 30 days
Self-efficacy
Self-efficacy will assess participant confidence in their ability to implement the skills learned from the intervention. We will develop the items as part of the study, and items will be identified based on the CBT principles and skill applications taught in the program. We will use a 5-point Likert scale of not at all confident (=1) to very confident (=5). A mean score will be computed, ranging from 1 to 5, with higher scores indicating greater self-efficacy in implementing the skills learned in the intervention.
Time frame: baseline; 30 days
Behavioral intentions
Behavioral intentions are participants' self-reported likelihood of implementing the skills learned from the intervention on a regular basis. We will develop the items as part of the study, and items will be identified based on the CBT principles and skill applications taught in the program. We will use a 5-point Likert scale of not at all likely (=1) to very likely (=5). A mean score will be computed, ranging from 1 to 5, with higher scores indicating a greater likelihood of implementing the skills learned in the intervention on a regular basis.
Time frame: baseline; 30 days
Dosage
Dosage is the number of sessions and skills practices a participant completes
Time frame: Through study completion, an average of 1 month
Plan to share: Yes — Data will be collected from 25 participants, generating 1 dataset with two assessment time points (baseline, 1-month post-enrollment) including information on participant demographics, knowledge, self-efficacy, and planned behavior. Raw data will be transformed using SPSS and used for statistical analysis. Participant identities, and individual de-identified data will be made available for sharing. All quantitative experimental data produced during the course of the project will be preserved and shared. To facilitate interpretation of the data, a data dictionary, statistical analysis plans, and data collection instruments will be created, shared, and associated with the relevant datasets. Aggregate clinical trials data from all arms of the study will be available in clinicaltrials.gov, along with related metadata. All other data described above in the "data to be shared" section will be deposited into the openICPSR repository.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Shared data generated from this project will be made available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data will be a minimum of 5 years after the end of the funding period.
Access criteria: Survey data will be made available in csv format and will not require the use of specialized tools to be accessed or manipulated.
No publications or documents are linked to this record.
Ran from Apr 2026 to primary completion in Jun 2026, 2 months.
Of 40 industry-sponsored interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 48. This study's 2 months is below that.
Counting every sponsor, half of 854 studies reached it within 34 months; a quarter within 17 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Research Behavioral Intervention Strategies, Inc. →